News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Anirban Maitra: The AI model developed for grading Barrett esophagus and dysplasia vs. GI Pathologists
Anirban Maitra/X
Jul 9, 2024, 06:17

Anirban Maitra: The AI model developed for grading Barrett esophagus and dysplasia vs. GI Pathologists

Anirban Maitra shared an article by Michel Botros et al. on X, adding the following:

“Open Access in Modern Pathology.

Deep Learning for Histopathological Assessment of Esophageal Adenocarcinoma Precursor Lesions

The AI model developed for grading Barrett esophagus & dysplasia outperformed 53 of 55 GI Pathologists in an existing dataset.”

Anirban Maitra: The AI model developed for grading Barrett esophagus and dysplasia vs. GI Pathologists

Anirban Maitra: The AI model developed for grading Barrett esophagus and dysplasia vs. GI Pathologists

Read the article.
Source: Anirban Maitra/X

Dr. Anriban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center.

He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

AI in pathology AI model Anirban Maitra Barrett esophagus cancer Deep learning dysplasia esophageal adenocarcinoma gastrointestinal pathology Healthcare Technology histopathology Medical Research Modern Pathology OncoDaily Oncology open access Pathology innovation
Special Coverage
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program